Health Condition 1: N130- Hydronephrosis with ureteropelvicjunction obstruction
Conditions
Interventions
Intervention1: Group A: Administration of continuous antibiotic prophylaxis post-pyeloplasty uptil stent removal: Group A will include 35 patients who will receive continuous antibiotic prophylaxis of
Sponsors
Bangalore Medical College and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: 1.Children between 0 to 16 years of age, undergoing open pyeloplasty with stent in-situ 2.Consent has been given by the parent or guardian, and assent from patients greater than 7 years of age.
Exclusion criteria
Exclusion criteria: 1.Patients with external stents, urethral catheters and nephrostomy tubes. 2.Patients with PUJO with any other congenital genitourinary tract abnormalities (vesicoureteral reflex, vesicoureteric junction obstruction, posterior urethral valves and neurogenic bladder). 3.Patients undergoing redo pyeloplasty.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare the frequency of febrile and asymptomatic culture positive urinary tract infections, with and without continuous antibiotic prophylaxis in pediatric patients with ureteric stents following pyeloplasty.Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify patient demographic factors causing incidence of symptomatic UTI (age, gender, duration of stent left in situ, socioeconomic status, unilateral vs bilateral stent insertion & bowel habits of the child) & whether the use of CAP can be restricted to those that fall under those categories.Timepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactAayushka Lodha
Bangalore Medical College and Research Institute
Outcome results
None listed